National Institutes of Health: all 11,571 studies

Page 34 of 116. Open to participants first (946), then studies with results posted, then the rest; newest registration first within each.

• Chemotherapy Plus Vaccination to Treat Mantle Cell LymphomaCompletedNCT00005780Phase 2Results posted
• An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral TherapyCompletedNCT00004978Phase 3Results posted
• Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast CancerCompletedNCT00004888Phase 2Results posted
• Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung CancerTerminatedNCT00004859Phase 3Results posted
• Thalidomide for the Treatment of Hormone-Dependent Prostate CancerCompletedNCT00004635Phase 3Results posted
• Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and ChemotherapyCompletedNCT00004547Phase 2Results posted
• Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBMCompletedNCT00004146Phase 2Results posted
• Vaccine Therapy in Treating HLA-A2 Positive Patients With MelanomaCompletedNCT00003895Phase 2Results posted
• Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung CancerCompletedNCT00003869Phase 3Results posted
• Specialized Blood Cell Transplants for Cancers of the Blood and Bone MarrowCompletedNCT00003838Phase 2Results posted
• Screening for Prostate Cancer in Older Patients (PLCO Screening Trial)Active, not recruitingNCT00002540Not applicableResults posted
• Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted KidneysCompletedNCT00001984Phase 2Results posted
• A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow FailureTerminatedNCT00001962Phase 2Results posted
• Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)CompletedNCT00001959Phase 2Results posted
• Anti-Tac for Treatment of LeukemiaCompletedNCT00001941Phase 1/2Results posted
• Stem Cell Transplantation for Metastatic Solid TumorsTerminatedNCT00001880Phase 2Results posted
• New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing SyndromeCompletedNCT00001849Phase 2Results posted
• Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic MelanomaCompletedNCT00001832Phase 2Results posted
• Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell CarcinomaTerminatedNCT00001703Phase 2Results posted
• Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic DisordersCompletedNCT00001656Phase 4Results posted
• Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression AnalysisCompletedNCT00001586Phase 2Results posted
• Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid LeukemiaCompletedNCT00001575Phase 1/2Results posted
• A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric SarcomasCompletedNCT00001566Phase 2Results posted
• Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal HyperplasiaCompletedNCT00001521Phase 3Results posted
• The Role of Hormones in Postpartum Mood DisordersCompletedNCT00001481Phase 2Results posted
• Treatment and Natural History Study of Lymphomatoid GranulomatosisCompletedNCT00001379Phase 2Results posted
• Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's LymphomaCompletedNCT00001337Phase 2Results posted
• The Effects of Reproductive Hormones on Mood and BehaviorCompletedNCT00001322Phase 1/2Results posted
• Growth Hormone Therapy in Osteogenesis ImperfectaCompletedNCT00001305Phase 3Results posted
• Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34CompletedNCT00001304Phase 2Results posted
• Studies of Elevated Parathyroid ActivityCompletedNCT00001277Phase 2Results posted
• Copper Histidine Therapy for Menkes DiseasesCompletedNCT00001262Phase 1/2Results posted
• A Treatment Study for Premenstrual Syndrome (PMS)CompletedNCT00001259Phase 1Results posted
• Cysteamine Eye Drops to Treat Corneal Crystals in CystinosisCompletedNCT00001213Phase 2Results posted
• Studies With 1,25-DihydroxycholecalciferolTerminatedNCT00001151Phase 2Results posted
• Action to Control Cardiovascular Risk in Diabetes (ACCORD)CompletedNCT00000620Phase 3Results posted
• Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.CompletedNCT00000392Phase 2Results posted
• Effects of Brief Nature Exposure on Brain Functioning and Stress ReactivityCompletedNCT07508800
• Quality of Care for Adolescent and Young Adult (AYA) Patients Living With Serious or Advanced CancerWithdrawnNCT07484282
• Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) TumorsCompletedNCT07374692
• Bispecific T-Cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previously Treated Extensive-Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine CancerWithdrawnNCT07328490Phase 1/2
• Blood Sampling Pre- and Post-Propofol Administration to Characterize the Blood Proteome Using Different Research AssaysCompletedNCT07295795
• Cefiderocol vs Best Available Therapy for Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex Infections: A Target Trial EmulationActive, not recruitingNCT07226557
• A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular RoutesActive, not recruitingNCT07221162Phase 1
• L9LS-R21 InteractionWithdrawnNCT07208760Phase 2
• Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in AdultsActive, not recruitingNCT07183709Phase 1
• Improving Physical Ability and Cellular Senescence Elimination in HIVCompletedNCT07144293Phase 2
• Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in AdultsCompletedNCT07095231Phase 1
• L9LS in Women of Childbearing Potential in MaliCompletedNCT07060508Phase 2
• A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)SuspendedNCT07055477Phase 1
• Exploring How to Adapt an Evidence-Based Mindful Self-Compassion Program for Young Adults With Li-Fraumeni SyndromeCompletedNCT07032922
• A Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Central Antigen mRNA-LNP in Healthy AdultsCompletedNCT07019883Phase 1
• Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile DermatomyositisWithdrawnNCT07012057Phase 2
• Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to BonesWithdrawnNCT06982222Phase 1
• A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIVActive, not recruitingNCT06919016Phase 1
• A Clinical Trial to Evaluate the Safety and Immunogenicity of Glycan-trimmed HIV-1 Nanoparticle Vaccine (UVAX-1107), Followed by Homologous or Wild-type HIV-1 Nanoparticle Vaccine (UVAX-1197) Boost, Each Adjuvanted With 3M-052-AF + Alum in Adult Participants Without HIVSuspendedNCT06905275Phase 1
• Metagenomics Next-generation Sequencing Approach to Detect Microbial DNA/RNA Overtime in Individuals Undergoing Hematopoietic Stem Cell TransplantCompletedNCT06904053
• Testing an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients With High-Risk Myelodysplastic Syndrome That Has Not Responded to Other TreatmentSuspendedNCT06888323Phase 1
• Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple MyelomaSuspendedNCT06876142Phase 1/2
• Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter PyloriCompletedNCT06871579Not applicable
• Safety and Challenge Study of BCG TICE(R) Vaccination to Test Tuberculosis Immunity in Heathy HumansWithdrawnNCT06845358Phase 1
• A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIVActive, not recruitingNCT06812494Phase 2
• Long-Term Neurologic and Neurocognitive Sequelae Following Pediatric Ebola Virus in LiberiaCompletedNCT06811129
• Evaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Challenge Compared to DENV and ZIKV-naïve Controls Against Infection With ZIKV-SJRP ChallengeCompletedNCT06805487Phase 1
• Testing the Combination of Targeted Radiotherapy With Anti-Cancer Drugs, Venetoclax and ASTX-727, to Improve Outcomes for Adults With Newly Diagnosed Acute Myeloid LeukemiaSuspendedNCT06802523Phase 1
• UrbanHEAT: Health Behaviors, Outcomes, and Disparities in Individually Experienced Temperature Across an Urban CommunityWithdrawnNCT06778252
• Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine in Healthy AdultsActive, not recruitingNCT06745921Phase 1
• Experience and Management of Cancer Screening-Related Anxiety in Fanconi AnemiaActive, not recruitingNCT06744283
• First-in-Human PfSPZ-LARC2 Vaccination/CHMICompletedNCT06735209Phase 1
• Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung CancerActive, not recruitingNCT06732401Phase 3
• CBX-12 for the Treatment of Metastatic Chemotherapy-Refractory Microsatellite Stable Colorectal CancerWithdrawnNCT06730100Phase 2
• Tecovirimat for Treatment of Monkeypox Virus - Study Extension Providing Standard of Care OnlyCompletedNCT06721585
• Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)CompletedNCT06709521Phase 4
• Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIVSuspendedNCT06705478Phase 2
• Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)SuspendedNCT06694454Phase 1/2
• Efficacy Study of IM Administered CssBA+dmLT Against Moderate-severe Diarrhea in Human Infection Model With ETEC Strain B7A in Healthy AdultsCompletedNCT06692907Phase 2
• A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal MalignanciesWithdrawnNCT06690281Phase 2
• Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral TherapySuspendedNCT06680479Phase 1
• Epcoritamab in Chronic Lymphocytic Leukemia and Richter SyndromeActive, not recruitingNCT06676033Phase 1
• Training to Modify Fixational Eye Movements for Optimizing Visual Performance in People With Central Vision LossActive, not recruitingNCT06670989Not applicable
• Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage MesotheliomaWithdrawnNCT06654050Phase 2
• Pre- vs Post-Pandemic Risk-adjusted Survival Rates in the US HospitalsActive, not recruitingNCT06651645
• Human Milk Oligosaccharide-Based Synbiotic Supplement for Intestinal Microbiota DysbiosisCompletedNCT06615986Early Phase 1
• Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)Active, not recruitingNCT06611553Not applicable
• Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)Active, not recruitingNCT06611540Not applicable
• Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC)WithdrawnNCT06603818Phase 2
• Promoting Upright Mobility in Infants With Cerebral Palsy Using a Robotic Unweighting SystemWithdrawnNCT06593886Phase 2
• Testing the Addition of an Investigational Anti-Cancer Drug, ASTX660 (Tolinapant), to a Usual Chemotherapy Treatment (Eribulin) for Treatment of Advanced Triple Negative Breast CancerWithdrawnNCT06590558Phase 1
• Study of a Human Bispecific Antibody VRC-HIVMAB0121-00-AB (CAP256J3LS) Administered Intravenously or Subcutaneously to Healthy AdultsCompletedNCT06585891Phase 1
• Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use DisorderSuspendedNCT06577454Not applicable
• Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin CancerSuspendedNCT06568172Phase 3
• CROSSOVER STUDY OF ON-DEMAND PREP FORMULATIONS COMPARING RECTAL AND ORAL TENOFOVIRCompletedNCT06560684Phase 2
• A Clinical Trial to Evaluate the Safety and Immunogenicity of CH505M5 N197D mRNA-gp160 Followed by CH505 TF mRNA-gp160 in Adults in Overall Good Health Without HIVActive, not recruitingNCT06557785Phase 1
• The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both ProductsCompletedNCT06551506Phase 4
• Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AMLSuspendedNCT06514261Phase 1
• The Tatelo Plus StudyActive, not recruitingNCT06508749Phase 1/2
• Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)Active, not recruitingNCT06498661Not applicable
• NHLBI and Cook Trans-Atrial Intra-Pericardial Tricuspid Annuloplasty (TRAIPTA) Early Feasibility StudySuspendedNCT06479824Not applicable
• Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid SprayWithdrawnNCT06461949Phase 3
• Safety and Immunogenicity Trial of MPV/S-2P SARS-CoV-2 Vaccine in AdultsCompletedNCT06441968Phase 1

← National Institutes of Health overview and focus areas